Miami-based global Clinical Research firm conducts life-impacting studies for Parkinson's drugs.
MIAMI, April 22, 2015 /PRNewswire/ — Biorasi, a full-service CRO powered by TALOS™, today announced efforts to support Parkinson's Month by donating to the National Parkinson's Foundation in honor of the millions of patients suffering with this disease. Biorasi works with leading pharmaceutical, biotech and medical device companies on all Phases of drug trials for Central Nervous System (CNS), Oncology, Endocrinology and some other indications. Parkinson's Awareness Month is the driving force energized by a conglomerate of patients, family members, hospitals, wellness centers and other not for profit and for profit organizations. Education, support, exposure and community influence are all goals of this outreach month of April as a long standing spotlight on this yet to be cured disease for people living with Parkinson's.
Photo – http://photos.prnewswire.com/prnh/20150421/200071
Logo – http://photos.prnewswire.com/prnh/20150421/200072LOGO
"During Parkinson's Awareness Month and beyond, we honor the one million Americans living with Parkinson's disease," said Joyce Oberdorf, President and CEO of the National Parkinson Foundation. "We are grateful for Biorasi's partnership to raise awareness of this disease and to help us fulfill our mission of improving the lives of people living with Parkinson's."
"Biorasi is pleased to support the National Parkinson's Foundation as we understand the complexities of the disease and the quest of our Sponsor customers to rapidly develop life impacting drugs," says Dr Boris Reznik, Chairman of Biorasi. "
About the National Parkinson Foundation (NPF)
Founded in 1957, the National Parkinson Foundation's mission is to improve the quality of care for people with Parkinson's disease through research, education and outreach. NPF has funded more than $189 million in care, research and support services. For more information about NPF, visit www.parkinson.org, or call the NPF Helpline at 1-800-4PD-INFO (473-4636).
About Biorasi
Biorasi is an award-winning Clinical Research Optimized™ CRO. From study design to execution success, optimization is engrained in TALOS™ the most robust and innovative operating platform in the industry. Equipped with TALOS™, Biorasi's full service project teams have developed numerous drugs, biologics and devices that received FDA and multi-venue approvals. Biorasi is headquartered in Miami, FL and has regional offices and operations across North America and around the world.
For more information: Biorasi Contact Form
Contact: Karen Bertoli Chief Marketing Officer | Email | (305) 216 4190